Menu UF Health Home Menu
 

News Category Subscribe to RSS Feed

education-headlines_20090225180434246_320_240

CDC: More U.S. schools ban junk food, soda ads

Published: Aug 27th, 2013

CDC data show that 44% of U.S. school districts had bans on junk foods from vending machines in 2012, an increase from 30% in 2006. Researchers also found that the percentage of districts that allowed soda advertisements in schools decreased from about 47% in 2006 to 33.5% in 2012, while the number of school districts that disclosed nutritional and caloric information of school meals to families grew from about 35% in 2000 to about 53% last year. Read more.

Shands UF front

UF laboratory to focus on study of diabetic retinopathy, among others

Published: Aug 27th, 2013

A $600,000 grant will allow the University of Florida to renovate existing lab space into a laboratory dedicated solely to producing more effective treatments to prevent vision loss and blindness. “Having this laboratory space will significantly enhance our ability to conduct essential research into the basic mechanisms of normal vision and disease. It also will offer the resources to develop translational projects that will create new therapies for diabetic retinopathy…and other retinal degenerations.” Read more.

ioa_logo1

Introducing the UF Clinical and Translational Research Building

Published: Aug 26th, 2013

The University of Florida recently celebrated the opening of the Clinical and Translational Research Building, a new home for research that will speed scientific discoveries to patients. The building houses an array of academic departments, clinical research programs, and Institutes including the Clinical and Translational Science Institute and, the UF Institute on Aging which focuses, in part, on the link(s) between diabetes and Alzheimer’s disease. Read more.

Heal Together

New campaign tackles diabetes complications: Are You At Risk?

Published: Aug 21st, 2013

Neuropathy is a serious and sometimes overlooked problem for patients with diabetes. The American Diabetes Associations estimates that 60-70% of diabetics have mild to severe nervous system damage. Learn how drug manufacturer Shire is educating everyone about a new risk assesment tool in addition to complications associated with having diabetes. Learn more.

T-Cell

Teplizumab benefits type 1 diabetes patients in midstage study

Published: Aug 9th, 2013

Type 1 diabetes patients who were on teplizumab, an experimental treatment, were able to maintain their insulin production rates for two years, longer than patients on most other diabetes medications, according to data from a Phase II study published in Diabetes. However, about half of patients did not benefit from the drug. Researchers said patients who saw the most benefit were those who still had good glucose control and moderate insulin requirements at the start of the study.

UF Health

See Dr. Atkinson featured in the new UF Health ad campaign

Published: Aug 1st, 2013

UF&Shands, the University of Florida Academic Health Center, is now University of Florida Health. The new umbrella term reflects the health system’s strong ties to UF, a key part of what differentiates the academic health center — with its focus on excellence in research, teaching and patient care — from its competitors. See how invisible connections are making a difference in the lives of every patient we serve.

insulin syringes resize

Making Insulin: Producing a lifesaving medication

Published: Jul 30th, 2013

Today, the insulin that comes in vials, pens, and pumps is not from pigs and cows but from pharmaceutical companies armed with the latest groundbreaking biotechnology. Join Diabetes Forecast Magazine for a behind-the-scenes look at the making of this lifesaving medication.

Insulet-New-OmniPod

Technology Corner: WellDoc app now available

Published: Jul 19th, 2013

WellDoc has announced the launch of BlueStar, an FDA approved prescription version of its “Diabetes Manager” program. BlueStar is the first disease therapy system to be prescribed through an app. WellDoc was designed for people with type 2 diabetes. The goal of this new mobile technology is to educate patients about type 2 diabetes and keep them engaged in their disease management. WellDoc is the first app to be eligible for reimbursement. Learn more.

Microscope

Autologous stem cells cut insulin requirements in T2DM

Published: Jul 17th, 2013

A study in Cell Transplantation found type 2 diabetes patients who received autologous bone marrow stem cells required lower insulin doses compared with those in the control group. Longer-duration studies with a larger number of participants will be needed to establish the efficacy of stem cell treatment in diabetes, researchers said. Read more.

Walgreens

Visit your local Walgreens and support JDRF!

Published: Jul 17th, 2013

From now through July 31st when you visit your local Walgreens, you can support JDRF by making a donation of $1, $2, $5, or $10 at checkout. The dollars raised through this campaign will help JDRF create a world without T1D. Walgreens has supported JDRF for 20 years, contributing more than $20 million to JDRF’s mission. Visit today!